 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter A - General |
|
|
Subpart B - Specific Sector Provisions for Medical Devices |
| § 26.31 - Purpose. |
| § 26.32 - Scope. |
| § 26.33 - Product coverage. |
| § 26.34 - Regulatory authorities. |
| § 26.35 - Length and purpose of transition period. |
| § 26.36 - Listing of CAB's. |
| § 26.37 - Confidence building activities. |
| § 26.38 - Other transition period activities. |
| § 26.39 - Equivalence assessment. |
| § 26.40 - Start of the operational period. |
| § 26.41 - Exchange and endorsement of quality system evaluation reports. |
| § 26.42 - Exchange and endorsement of product evaluation reports. |
| § 26.43 - Transmission of quality system evaluation reports. |
| § 26.44 - Transmission of product evaluation reports. |
| § 26.45 - Monitoring continued equivalence. |
| § 26.46 - Listing of additional CAB's. |
| § 26.47 - Role and composition of the Joint Sectoral Committee. |
| § 26.48 - Harmonization. |
| § 26.49 - Regulatory cooperation. |
| § 26.50 - Alert system and exchange of postmarket vigilance reports. |
| Appendix A to Subpart B of Part 26 - Relevant Legislation, Regulations, and Procedures. |
| Appendix B to Subpart B of Part 26 - Scope of Product Coverage |
| Appendixes C-F to Subpart B of Part 26 - [Reserved] |
| Appendixes C-F to Subpart B of Part 26 - [Reserved] |